Study: E-cigarette Aerosol Enhances Optical Imaging of Lung Tissue

Nov.24.2023
Study: E-cigarette Aerosol Enhances Optical Imaging of Lung Tissue
Russian researchers from Saratov and Tomsk universities have found that e-cigarette aerosols can enhance lung tissue contrast, potentially improving accuracy in diagnosing lung diseases.

According to a report from ABnews, research teams from two state universities in Saratov and Tomsk, Russia have recently published a study in the journal Diagnostics. The study suggests that aerosols in e-cigarettes can enhance the optical imaging contrast in lung tissue, offering the potential to improve the accuracy of diagnosing lung diseases.


This experiment simulated the use of e-cigarettes and was conducted on rats. It found that the morphology of lung tissue formation is altered by the inhalation of e-cigarette aerosol, affecting its gas exchange capabilities.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Boton Group Announces Temporary Trading Halt Pending Major Disposal Announcement
China Boton Group Announces Temporary Trading Halt Pending Major Disposal Announcement
China Boton Group Company Limited (Stock Code: 3318) announced that trading in its shares on the Hong Kong Stock Exchange (HKEX) was temporarily suspended at 9 a.m. on December 8, 2025. The suspension was requested by the company pending the release of an announcement related to a “very substantial disposal.”
Dec.08 by 2FIRSTS.ai
JTI Plans New Factory in Romania, Set for Completion in 2027
JTI Plans New Factory in Romania, Set for Completion in 2027
JTI has announced plans to build a new factory in Ștefăneștii de Jos to replace its current Bucharest site, which faces space constraints. The project is expected to be completed in 2027, with ground works starting soon. The company highlighted ongoing efforts to expand capacity and modernize its Romanian operations.
Nov.28
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
In Nepal’s Mustang district, authorities seized 80 cartons of e-cigarettes valued at NPR 22,459,320 (approximately US$150,000) in Lomanthang Rural Municipality-4, Nechung, and detained a 32-year-old man, Pema Lama. The account says the e-cigarettes were allegedly brought illegally from China three to four days earlier and loaded near the Korala Nepal–China border point before being intercepted.
Jan.13 by 2FIRSTS.ai
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
New York City has reached settlement agreements with two e-cigarette wholesalers accused of selling flavored vapes illegally. The companies agreed to stop all flavored vape transactions in the city and face $1,000 fines for future violations. Litigation against other defendants in the broader case continues.
Nov.25 by 2FIRSTS.ai